, Volume 19, Issue 5–6, pp 133–134 | Cite as

Carcinome hépatocellulaire : nous sommes à l’aube d’une nouvelle époque !

Éditorial / Editorial

Hepatocellular carcinoma: We are at the dawn of a new era!


  1. 1.
    Goutte N, Sogni P, Bendersky N, et al (2017) Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country. J Hepatol 66:537–44CrossRefPubMedGoogle Scholar
  2. 2.
    Siegel AB, Zhu AX (2009) Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 115:5651–61CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Paradis V, Zalinski S, Chelbi E, et al (2009) Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 49: 851–9CrossRefPubMedGoogle Scholar
  4. 4.
    van der Meer AJ, Berenguer M (2016) Reversion of disease manifestations after HCV eradication. J Hepatol 65:S95–S108CrossRefPubMedGoogle Scholar
  5. 5.
    Trinchet JC, Chaffaut C, Bourcier V, et al (2011) Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3-and 6-month periodicities. Hepatology 54: 1987–97CrossRefPubMedGoogle Scholar
  6. 6.
    Barbare JC, Franco D, Andre T, et al (2014) Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings? Bull Cancer 101:558–63PubMedGoogle Scholar
  7. 7.
    European Association for the Study of The Liver, European Organisation for Research and Treatment of Cancer (2012) EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–43CrossRefGoogle Scholar

Copyright information

© Lavoisier 2017

Authors and Affiliations

  1. 1.Département d’oncologie médicaleinstitut Paoli-CalmettesMarseilleFrance

Personalised recommendations